Skip to content

Released Feb 23, 2011, after the close

10-K filed Feb 23, 2011, 54 days after period end · 0000950123-11-017213

Q4 2010 · 10-K

derived · Computed from the longer spans the company filed.

Revenue—
Net income—
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Cash Flowderived-$8,031,000—
Free Cash Flowderived-$9,070,000—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

no prior Q4 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Protalix BioTherapeutics, Inc. · CIK 1006281 · Engraved from SEC EDGAR